Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

ImmunityBio (IBRX) Income from Non-Controlling Interests (2020 - 2025)

ImmunityBio (IBRX) has disclosed Income from Non-Controlling Interests for 6 consecutive years, with -$14000.0 as the latest value for Q4 2025.

  • Quarterly Income from Non-Controlling Interests rose 17.65% to -$14000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$74000.0 through Dec 2025, up 8.64% year-over-year, with the annual reading at -$74000.0 for FY2025, 8.64% up from the prior year.
  • Income from Non-Controlling Interests for Q4 2025 was -$14000.0 at ImmunityBio, up from -$21000.0 in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was -$14000.0 in Q4 2025, with the low at -$1.1 million in Q2 2021.
  • Average Income from Non-Controlling Interests over 5 years is -$231100.0, with a median of -$85500.0 recorded in 2022.
  • The sharpest move saw Income from Non-Controlling Interests tumbled 122.88% in 2021, then surged 94.01% in 2024.
  • Over 5 years, Income from Non-Controlling Interests stood at -$294000.0 in 2021, then skyrocketed by 62.24% to -$111000.0 in 2022, then soared by 80.18% to -$22000.0 in 2023, then grew by 22.73% to -$17000.0 in 2024, then rose by 17.65% to -$14000.0 in 2025.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods came in at -$14000.0, -$21000.0, and -$19000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.